Kura Oncology (KURA)
(Delayed Data from NSDQ)
$20.59 USD
+0.31 (1.53%)
Updated May 2, 2024 04:00 PM ET
After-Market: $17.43 -3.16 (-15.35%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Brokerage Reports
0 items in cart
Kura Oncology, Inc. [KURA]
Reports for Purchase
Showing records 241 - 254 ( 254 total )
Company: Kura Oncology, Inc.
Industry: Medical - Biomedical and Genetics
Q1 Financials; Significant Program Updates Expected in 2H18
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Kura Oncology, Inc.
Industry: Medical - Biomedical and Genetics
Company: Kura Oncology, Inc.
Industry: Medical - Biomedical and Genetics
Company: Kura Oncology, Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Kura Oncology, Inc.
Industry: Medical - Biomedical and Genetics
Company: Kura Oncology, Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Kura Oncology, Inc.
Industry: Medical - Biomedical and Genetics
Q4 Financials; Positive EoP2 Meeting Provides Clear Path for Tipifarnib
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Kura Oncology, Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Kura Oncology, Inc.
Industry: Medical - Biomedical and Genetics
Improved Response Rate for Tipifarnib in HRAS-Mutant HNSCC
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Kura Oncology, Inc.
Industry: Medical - Biomedical and Genetics
Company: Kura Oncology, Inc.
Industry: Medical - Biomedical and Genetics
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Kura Oncology, Inc.
Industry: Medical - Biomedical and Genetics
Company: Kura Oncology, Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Kura Oncology, Inc.
Industry: Medical - Biomedical and Genetics
Initiating with an OUTPERFORM and $19 PT: Tip-ping the Balance to Success
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R